InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Monday, 03/02/2020 3:32:40 PM

Monday, March 02, 2020 3:32:40 PM

Post# of 474
More clinical updates and Analysts upgrades coming Biogen now owns% of SGMO $350 Million up front with possible 2-3 Billion royalties. This is just on a few of sgmo trials there is a wide array of trials in gene editing field. Cash runway into 2023 Biogen will buy them before that.

https://www.sangamo.com/pipeline


$SGMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SGMO News